The role of the gastrointestinal tract in phosphate homeostasis in health and chronic kidney disease

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue 4, 2013, Pages 481-487

  Marks, Joanne ^a   Debnam, Edward S ^a   Unwin, Robert J ^a  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

Author keywords

Chronic kidney disease; Intestine; NaPi IIb; Phosphate toxicity

Indexed keywords

FIBROBLAST GROWTH FACTOR 23; GLUCOSE TRANSPORTER 2; MATRIX EXTRACELLULAR PHOSPHOGLYCOPROTEIN; PHOSPHATE; PHOSPHATE TRANSPORTER; SECRETED FRIZZLED RELATED PROTEIN 4; SODIUM ION; TISSUE EXTRACT;

CHRONIC KIDNEY DISEASE; GASTROINTESTINAL TRACT; GASTROINTESTINAL TRACT FUNCTION; GLUCOSE ABSORPTION; GLUCOSE TRANSPORT; HEALTH; HUMAN; HYPERPHOSPHATEMIA; INTESTINE ABSORPTION; ION TRANSPORT; KIDNEY; MOUSE; NONHUMAN; PASSIVE TRANSPORT; PHOSPHATE BALANCE; PHOSPHATE BLOOD LEVEL; PHOSPHATE EXCRETION; PHOSPHATE INTAKE; PHOSPHATE METABOLISM; PHOSPHATE TRANSPORT; PHOSPHATE URINE LEVEL; PHOSPHATURIA; PRIORITY JOURNAL; PROTEIN EXPRESSION; REVIEW; RISK FACTOR; SIGNAL TRANSDUCTION; SMALL INTESTINE; STEADY STATE;

ANIMALS; FOOD PRESERVATIVES; HOMEOSTASIS; HUMANS; HYPERPHOSPHATEMIA; INTESTINAL ABSORPTION; INTESTINES; MICE; MICE, KNOCKOUT; PHOSPHATES; PHOSPHORUS, DIETARY; RENAL INSUFFICIENCY, CHRONIC; SODIUM-PHOSPHATE COTRANSPORTER PROTEINS, TYPE IIB;

EID: 84879215937     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e3283621310     Document Type: Review

References (59)

1. Indridason OS, Quarles LD. Hyperphosphatemia in end-stage renal disease. Adv Ren Replace Ther 2002; 9:184-192.
2. Block GA, Hulbert-Shearon TE, Levin NW, Port FK. Association of serum phosphorus and calcium x phosphate product with mortality risk in chronic hemodialysis patients: a national study. Am J Kidney Dis 1998; 31:607-617.
3. Hill KM, Martin BR, Wastney ME, et al. Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease. Kidney Int 2012. doi:10.1038/ki.2012.403. [Epub ahead of print]
4. Adeney KL, Siscovick DS, Ix JH, et al. Association of serum phosphate with vascular and valvular calcification in moderate CKD. J Am Soc Nephrol 2009; 20:381-387.
5. Isakova T, Xie H, Yang W, et al. Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease. JAMA 2011; 305:2432-2439.
6. Lim K, Lu TS, Molostvov G, et al. Vascular Klotho deficiency potentiates the development of human artery calcification and mediates resistance to fibroblast growth factor 23. Circulation 2012; 125:2243-2255.
7. Dominguez JR, Shlipak MG, Whooley MA, Ix JH. Fractional excretion of phosphorus modifies the association between fibroblast growth factor-23 and outcomes. J Am Soc Nephrol 2013; 24:647-654.
8. Frazao JM, Adragao T. Noncalcium-containing phosphate binders: comparing efficacy, safety, and other clinical effects. Nephron Clin Pract 2012; 120: c108-c119.
9. Kovesdy CP, Kuchmak O, Lu JL, Kalantar-Zadeh K. Outcomes associated with phosphorus binders in men with nondialysis-dependent CKD. Am J Kidney Dis 2010; 56:842-851.
10. Di IB, Bellasi A, Russo D. Mortality in kidney disease patients treated with phosphate binders: a randomized study. Clin J Am Soc Nephrol 2012; 7:487-493.
11. Block GA, Wheeler DC, Persky MS, et al. Effects of phosphate binders in moderate CKD. J Am Soc Nephrol 2012; 23:1407-1415.
12. Tonelli M, Sacks F, Pfeffer M, et al. Relation between serum phosphate level and cardiovascular event rate in people with coronary disease. Circulation 2005; 112:2627-2633.
13. Cancela AL, Santos RD, Titan SM, et al. Phosphorus is associated with coronary artery disease in patients with preserved renal function. PLoS One 2012; 7:e36883.
14. Razzaque MS. Phosphate toxicity: new insights into an old problem. Clin Sci (Lond) 2011; 120:91-97.
15. Ohnishi M, Razzaque MS. Dietary and genetic evidence for phosphate toxicity accelerating mammalian aging. FASEB J 2010; 24:3562-3571.
16. Dhingra R, Sullivan LM, Fox CS, et al. Relations of serum phosphorus and calcium levels to the incidence of cardiovascular disease in the community. Arch Intern Med 2007; 167:879-885.
17. Takeda E, Yamamoto H, Yamanaka-Okumura H, Taketani Y. Dietary phosphorus in bone health and quality of life. Nutr Rev 2012; 70:311-321.
18. Karp HJ, Kemi VE, Lamberg-Allardt CJ, Karkkainen MU. Mono- and polyphosphates have similar effects on calcium and phosphorus metabolism in healthy young women. Eur J Nutr 2013; 52:991-996.
19. Gutierrez OM, Anderson C, Isakova T, et al. Low socioeconomic status associates with higher serum phosphate irrespective of race. J Am Soc Nephrol 2010; 21:1953-1960.
20. Kalantar-Zadeh K, Gutekunst L, Mehrotra R, et al. Understanding sources of dietary phosphorus in the treatment of patients with chronic kidney disease. Clin J Am Soc Nephrol 2010; 5:519-530.
21. Uribarri J. Phosphorus additives in food and their effect in dialysis patients. Clin J Am Soc Nephrol 2009; 4:1290-1292.
22. Benini O, D'Alessandro C, Gianfaldoni D, Cupisti A. Extra-phosphate load from food additives in commonly eaten foods: a real and insidious danger for renal patients. J Ren Nutr 2011; 21:303-308.
23. Walling MW. Intestinal Ca and phosphate transport: differential responses to vitamin D3 metabolites. Am J Physiol 1977; 233:E488-E494.
24. Danisi G, Murer H. Inorganic phosphate absorption in small intestine. Handbook of physiology. The gastrointestinal system. Vol IV; 1991. pp. 323-336.
25. Borowitz SM, Granrud GS. Ontogeny of intestinal phosphate absorption in rabbits. Am J Physiol 1992; 262:G847-G853.
26. Lee DB, Walling MW, Corry DB. Phosphate transport across rat jejunum: influence of sodium, pH, and 1,25-dihydroxyvitamin D3. Am J Physiol 1986; 251:G90-G95.
27. Borowitz SM, Ghishan FK. Phosphate transport in human jejunal brush-border membrane vesicles. Gastroenterology 1989; 96:4-10.
28. Murer H, Forster I, Biber J. The sodium phosphate cotransporter family SLC34. Pflugers Arch 2004; 447:763-767.
29. Marks J, Debnam ES, Unwin RJ. Phosphate homeostasis and the renal-gastrointestinal axis. Am J Physiol Renal Physiol 2010; 299:F285-F296.
30. Sabbagh Y, Giral H, Caldas Y, et al. Intestinal phosphate transport. Adv Chronic Kidney Dis 2011; 18:85-90.
31. Ohi A, Hanabusa E, Ueda O, et al. Inorganic phosphate homeostasis in sodium-dependent phosphate cotransporter Npt2b(+)/(-) mice. Am J Physiol Renal Physiol 2011; 301:F1105-F1113.
32. Shibasaki Y, Etoh N, Hayasaka M, et al. Targeted deletion of the tybe IIb Na(+)-dependent Pi-co-transporter, NaPi-IIb, results in early embryonic lethality. Biochem Biophys Res Commun 2009; 381:482-486.
33. Sabbagh Y, O'Brien SP, Song W, et al. Intestinal Npt2b plays a major role in phosphate absorption and homeostasis. J Am Soc Nephrol 2009; 20:2348-2358.
34. Schiavi SC, Tang W, Bracken C, et al. Npt2b deletion attenuates hyperphosphatemia associated with CKD. J Am Soc Nephrol 2012; 23:1691-1700.
35. Danisi G, Bonjour JP, Straub RW. Regulation of Na-dependent phosphate influx across the mucosal border of duodenum by 1,25-dihydroxycholecalci-ferol. Pflugers Arch 1980; 388:227-232.
36. Katai K, Tanaka H, Tatsumi S, et al. Nicotinamide inhibits sodium-dependent phosphate cotransport activity in rat small intestine. Nephrol Dial Transplant 1999; 14:1195-1201.
37. Katai K, Miyamoto K, Kishida S, et al. Regulation of intestinal Na+-dependent phosphate co-transporters by a low-phosphate diet and 1,25-dihydroxyvitamin D3. Biochem J 1999; 343:705-712.
38. Amasheh S, Fromm M, Gunzel D. Claudins of intestine and nephron: a correlation of molecular tight junction structure and barrier function. Acta Physiol (Oxf) 2011; 201:133-140.
39. Madara JL, Pappenheimer JR. Structural basis for physiological regulation of paracellular pathways in intestinal epithelia. J MembrBiol 1987; 100:149-164.
40. Kellett GL, Brot-Laroche E, Mace OJ, Leturque A. Sugar absorption in the intestine: the role of GLUT2. Annu Rev Nutr 2008; 28:35-54.
41. Helliwell PA, Richardson M, Affleck J, Kellett GL. Stimulation of fructose transport across the intestinal brush-border membrane by PMA is mediated by GLUT2 and dynamically regulated by protein kinase C. Biochem J 2000; 350:149-154.
42. Giral H, Caldas Y, Sutherland E, et al. Regulation of the rat intestinal Na-dependent phosphate transporters by dietary phosphate. Am J Physiol Renal Physiol 2009; 297:F1466-F1475.
43. Reining SC, Liesegang A, Betz H, et al. Expression of renal and intestinal Na/Pi cotransporters in the absence of GABARAP. Pflugers Arch 2010; 460:207-217.
44. Arima K, Hines ER, Kiela PR, et al. Glucocorticoid regulation and glycosylation of mouse intestinal type IIb Na-P(i) cotransporter during ontogeny. Am J Physiol Gastrointest Liver Physiol 2002; 283:G426-G434.
45. Xu H, Bai L, Collins JF, Ghishan FK. Age-dependent regulation of rat intestinal type IIb sodium-phosphate cotransporter by 1,25-(OH)(2) vitamin D(3). Am J Physiol Cell Physiol 2002; 282:C487-C493.
46. Segawa H, Kaneko I, Takahashi A, et al. Growth-related renal type II Na/Pi cotransporter. J Biol Chem 2002; 277:19665-19672.
47. Corut A, Senyigit A, Ugur SA, et al. Mutations in SLC34A2 cause pulmonary alveolar microlithiasis and are possibly associated with testicular microlithiasis. Am J Hum Genet 2006; 79:650-656.
48. Olauson H, Brandenburg V, Larsson TE. Mutation analysis and serum FGF23 level in a patient with pulmonary alveolar microlithiasis. Endocrine 2010; 37:244-248.
49. Marks J, Churchill LJ, Srai SK, et al. Intestinal phosphate absorption in a model of chronic renal failure. Kidney Int 2007; 72:166-173.
50. Moe SM, Radcliffe JS, White KE, et al. The pathophysiology of early-stage chronic kidney disease-mineral bone disorder (CKD-MBD) and response to phosphate binders in the rat. J Bone Miner Res 2011; 26:2672-2681.
51. Berndt T, Thomas LF, Craig TA, et al. Evidence for a signaling axis by which intestinal phosphate rapidly modulates renal phosphate reabsorption. Proc Natl Acad Sci U S A 2007; 104:11085-11090.
52. Marks J, Srai SK, Biber J, et al. Intestinal phosphate absorption and the effect of vitamin D: a comparison of rats with mice. Exp Physiol 2006; 91:531-537.
53. Marks J, Churchill LJ, Debnam ES, Unwin RJ. Matrix extracellular phosphoglycoprotein inhibits phosphate transport. J Am Soc Nephrol 2008; 19: 2313-2320.
54. Khuituan P, Teerapornpuntakit J, Wongdee K, et al. Fibroblast growth factor-23 abolishes 1,25-dihydroxyvitamin D(3)-enhanced duodenal calcium transport in male mice. Am J Physiol Endocrinol Metab 2012; 302:E903-E913.
55. Dermaku-Sopjani M, Sopjani M, Saxena A, et al. Downregulation of NaPi-IIa and NaPi-IIb Na-coupled phosphate transporters by coexpression of Klotho. Cell Physiol Biochem 2011; 28:251-258.
56. Wolf M. Update on fibroblast growth factor 23 in chronic kidney disease. Kidney Int 2012; 82:737-747.
57. Wolf M. Forging forward with 10 burning questions on FGF23 in kidney disease. J Am Soc Nephrol 2010; 21:1427-1435.
58. Ito N, Fukumoto S, Takeuchi Y, et al. Effect of acute changes of serum phosphate on fibroblast growth factor (FGF)23 levels in humans. J Bone Miner Metab 2007; 25:419-422.
59. Burnett-Bowie SM, Mendoza N, Leder BZ. Effects of gonadal steroid withdrawal on serum phosphate and FGF-23 levels in men. Bone 2007; 40:913-918.